FIFTH THIRD BANCORP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$20,252
-75.6%
1,254
-37.4%
0.00%
Q2 2023$83,166
+37.7%
2,004
+99.6%
0.00%
Q1 2023$60,381
-74.6%
1,004
-69.0%
0.00%
-100.0%
Q4 2022$237,287
+33.3%
3,235
+38.3%
0.00%0.0%
Q3 2022$178,000
+143.8%
2,339
+123.6%
0.00%
Q2 2022$73,000
-16.1%
1,0460.0%0.00%
Q1 2022$87,000
+11.5%
1,046
+0.8%
0.00%
Q4 2021$78,000
-32.8%
1,038
+3.8%
0.00%
-100.0%
Q3 2021$116,000
-48.4%
1,000
-1.6%
0.00%0.0%
Q2 2021$225,000
+70.5%
1,016
+1.6%
0.00%0.0%
Q1 2021$132,000
-80.5%
1,000
-74.5%
0.00%
-66.7%
Q4 2020$678,000
+129.8%
3,921
+47.9%
0.00%
+50.0%
Q3 2020$295,000
+109.2%
2,651
+11.3%
0.00%
+100.0%
Q2 2020$141,000
+80.8%
2,381
+104.7%
0.00%0.0%
Q1 2020$78,000
-8.2%
1,163
+15.7%
0.00%
Q4 2019$85,000
+32.8%
1,005
+17.0%
0.00%
Q3 2019$64,000
-42.9%
859
-51.5%
0.00%
-100.0%
Q2 2019$112,000
+60.0%
1,772
+21.9%
0.00%
Q1 2019$70,000
+141.4%
1,454
+66.0%
0.00%
Q4 2018$29,000
-35.6%
876
+1.5%
0.00%
Q3 2018$45,000
+80.0%
863
+8.0%
0.00%
Q2 2018$25,0007990.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders